Monkeypox Virus Antibodies in Healthy Persons after Vaccination with MVA-BN, United Kingdom
A 2-dose regimen of the vaccine modified vaccinia Ankara–Bavarian Nordic (MVA-BN) can generate neutralizing antibodies for monkeypox virus clades Ib and IIb. We observed higher response to clade IIb; that result provides evidence that MVA-BN vaccination can induce cross-neutralizing antibodies for...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Centers for Disease Control and Prevention
2026-02-01
|
| シリーズ: | Emerging Infectious Diseases |
| 主題: | |
| オンライン･アクセス: | https://wwwnc.cdc.gov/eid/article/32/2/25-1553_article |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|